… who had never received ICS or systemic corticosteroids. This study suggested that
asthmatic patients treated with high-dose inhaled BDP and intermittent systemic corticosteroids …

… inhaled corticosteroid treatment in patients with asthma or COPD. Overall, COPD patients
treated with inhaled corticosteroids … fewer exacerbations than patients taking placebo (relative …

… Elevated levels of systemic and pulmonary inflammation in patients with stable COPD
have led to the development of inhaled corticosteroid (ICS) therapies for such patients. These …

… for patients with asthma, but their role in treating patients with … inhaled corticosteroids are
of functional benefit in patients who did not show improvement with a trial of oral corticosteroids…

… their activity, but this does not appear to occur in asthmatic patients treated with inhaled
corticosteroids [14]. Corticosteroid-activated GR also interact with coactivator molecules and this …

… 33 The aim of this preliminary study was to investigate the effects on airway inflammation of
short-term treatment with high-dose inhaled corticosteroids in stable patients with mild COPD …

… patients with COPD. This article is based on a review of the literature (PubMed: COPD AND
inhaled corticosteroids… evidence for the efficacy and safety of ICS use in patients with COPD. …

… Inhaled corticosteroids are effective in most patients with asthma, irrespective of age or …
that occur in some patients. The dose-response curve to inhaled corticosteroids is relatively flat, …

… patients treated with high doses of inhaled corticosteroids for long periods. Although this
may well be an acceptable hazard for the minority of patients with severe asthma, the majority …

… the inhaled corticosteroid fluticasone propionate (FP) on exacerbations and health-related
quality of life in patients … After 4 months of treatment with FP (1,000 μg/day), 244 patients were …